Restless Legs Syndrome

Descriptive text is not available for this image Basics

Description

  • Sensorimotor disorder consisting of a strong urge to move the limbs; legs commonly affected initially but may involve arms/other body parts
  • Symptoms begin/worsen during rest or inactivity; relief of symptoms with movement
  • Often occurs in the evening
  • Involuntary leg jerks reported during wake/sleep
  • Early-onset phenotype: 40–60% familial, stable, slow progression of symptoms
  • Late-onset phenotype: more aggravating factors and rapid progression
  • Synonym(s): Willis-Ekbom disease

Epidemiology

Prevalence

Estimated 5–15% of the population. Women are affected more than men (1).Pregnancy Considerations

  • 10–30% prevalence; triggers/exacerbates RLS
  • Predictors: past history (Hx), family Hx, iron deficiency (ID), Hgb ≤11 g/dL (2)[C]
  • Peaks in 3rd trimester
  • Most symptoms are relieved by 1-month postpartum.

Etiology and Pathophysiology

  • Brain iron deficiency (BID), from low serum iron or impaired transport of iron into the brain, leading to CNS dopamine dysregulation:
    • Higher than normal dopamine agonists (DA) levels in the morning leading to DA D2 receptors downregulation
    • Lower than normal DA at night
    • Increased glutamate and decreased adenosine leading to hyperarousal and insomnia
  • Sensorimotor pathways abnormalities and increased motor excitability
  • Triggered by prolonged immobility, such as hospitalizations
  • Medication induced:
    • Most antidepressants: mirtazapine, TCAs, SSRIs, SNRIs
    • DA-blocking antiemetics (e.g., metoclopramide, prochlorperazine).
    • Phenothiazine antipsychotics (risperidone, clozapine, olanzapine, quetiapine, etc.); possible exception: aripiprazole (partial D2 agonist)
    • PPIs, H2 blockers (increase risk)
    • Theophylline and other xanthines
    • Sedating antihistamines
    • Melatonin may exacerbate symptoms (3).

Genetics

  • Susceptibility loci: 2p14, 2q, 6p21.2, 9p, 12q, 14q, 15q23, and 20p
  • Genes: MEIS1, BTBD9, PTPRD, TOX3, MAP2K5/LBXCOR1

Risk Factors

  • ID, vitamin D deficiency
  • Family Hx
  • End-stage renal disease
  • Temperature (cold weather, other environmental factors may increase incidence/trigger symptoms) (4)
  • Pregnancy

General Prevention

  • Regular physical activity during the day, low-impact activity at night such as stretches, walks
  • Adequate sleep quality/quantity; delay wake time if possible.
  • Avoid caffeine, alcohol, nicotine mainly in the evening.
  • Avoid meds that may trigger RLS (5)[C].

Commonly Associated Conditions

  • Insomnia, delayed sleep phase
  • ID, renal disease/uremia/dialysis, gastric surgery, IBS
  • Parkinson disease, multiple sclerosis, peripheral neuropathy, Machado-Joseph disease, migraines
  • Anxiety, depression, ADHD
  • Cardiovascular disease, diabetes mellitus, pulmonary hypertension, COPD

There's more to see -- the rest of this topic is available only to subscribers.